OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
28 hedge funds and large institutions have $7.09M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
28
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$714K | |
| 2 | +$221K | |
| 3 | +$209K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$102K |
| 5 |
Squarepoint
New York
|
+$90K |
Top Sellers
| 1 | -$373K | |
| 2 | -$179K | |
| 3 | -$138K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$32K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$29.7K |